These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9039169)

  • 1. Topical calcipotriol in childhood psoriasis.
    Oranje AP; Marcoux D; Svensson A; Prendiville J; Krafchik B; Toole J; Rosenthal D; de Waard-van der Spek FB; Molin L; Axelsen M
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):203-8. PubMed ID: 9039169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcipotriol ointment versus cream in psoriasis vulgaris.
    Duweb G; Aldebani S; Elzorghany A; Benghazil M; Alhaddar J
    Int J Clin Pharmacol Res; 2003; 23(2-3):47-51. PubMed ID: 15018018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. A randomized, double-blind, right/left comparative, vehicle-controlled study.
    Dubertret L; Wallach D; Souteyrand P; Perussel M; Kalis B; Meynadier J; Chevrant-Breton J; Beylot C; Bazex JA; Jurgensen HJ
    J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):983-8. PubMed ID: 1479106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled, randomized, right-left study comparing calcipotriol monotherapy with a combined treatment of calcipotriol and diflucortolone valerate in chronic plaque psoriasis.
    Salmhofer W; Maier H; Soyer HP; Hönigsmann H; Hödl S
    Acta Derm Venereol Suppl (Stockh); 2000; (211):5-8. PubMed ID: 11234559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris.
    Gollnick H; Altmeyer P; Kaufmann R; Ring J; Christophers E; Pavel S; Ziegler J
    Dermatology; 2002; 205(1):46-53. PubMed ID: 12145434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas.
    Ortonne JP; Humbert P; Nicolas JF; Tsankov N; Tonev SD; Janin A; Czernielewski J; Lahfa M; Dubertret L
    Br J Dermatol; 2003 Feb; 148(2):326-33. PubMed ID: 12588387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: results of a multicenter placebo-controlled study.
    Grossman RM; Thivolet J; Claudy A; Souteyrand P; Guilhou JJ; Thomas P; Amblard P; Belaich S; de Belilovsky C; de la Brassinne M
    J Am Acad Dermatol; 1994 Jul; 31(1):68-74. PubMed ID: 8021375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of calcipotriol ointment (Dovonex) in treating children with psoriasis vulgaris.
    Darley CR; Cunliffe WJ; Green CM; Hutchinson PE; Klaber MR; Downes N
    Br J Dermatol; 1996 Sep; 135(3):390-3. PubMed ID: 8949431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study to assess the safety and efficacy of topical calcipotriol treatment in childhood psoriasis.
    Park SB; Suh DH; Youn JI
    Pediatr Dermatol; 1999; 16(4):321-5. PubMed ID: 10469423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
    Lahfa M; Mrowietz U; Koenig M; Simon JC
    Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of calcipotriol (0.005%) ointment and tazarotene (0.05% and 0.1%) gel in the treatment of stable plaque psoriasis.
    Kaur I; Dogra S; Jain R; Kumar B
    Indian J Dermatol Venereol Leprol; 2008; 74(5):471-4. PubMed ID: 19052406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of calcipotriol (MC903) solution and placebo (vehicle of MC903) in the treatment of psoriasis of the scalp.
    Green C; Ganpule M; Harris D; Kavanagh G; Kennedy C; Mallett R; Rustin M; Downes N
    Br J Dermatol; 1994 Apr; 130(4):483-7. PubMed ID: 8186114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcipotriol plus short-contact dithranol: a novel topical combination therapy for chronic plaque psoriasis.
    Monastirli A; Georgiou S; Pasmatzi E; Sakkis T; Badavanis G; Drainas D; Sagriotis A; Tsambaos D
    Skin Pharmacol Appl Skin Physiol; 2002; 15(4):246-51. PubMed ID: 12218286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of accurate dosage of topical agents: a method of estimating involved area and application to calcipotriol treatment failures.
    Osborne JE; Hutchinson PE
    J Eur Acad Dermatol Venereol; 2002 Jul; 16(4):367-73. PubMed ID: 12224694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of topical calcipotriol versus coal tar and salicylic acid ointment in chronic plaque psoriasis.
    Singh P; Gupta S; Abidi A; Krishna A
    J Drugs Dermatol; 2013 Aug; 12(8):868-73. PubMed ID: 23986159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris.
    Kragballe K; Gjertsen BT; De Hoop D; Karlsmark T; van de Kerkhof PC; Larkö O; Nieboer C; Roed-Petersen J; Strand A; Tikjøb G
    Lancet; 1991 Jan; 337(8735):193-6. PubMed ID: 1670840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial.
    de Jong EM; Mørk NJ; Seijger MM; De La Brassine M; Lauharanta J; Jansen CT; Guilhou JJ; Guillot B; Ostrojic A; Souteyrand P; Vaillant L; Barnes L; Rogers S; Klaber MR; Van De Kerkhof PC
    Br J Dermatol; 2003 Feb; 148(2):318-25. PubMed ID: 12588386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
    Molin L; Cutler TP; Helander I; Nyfors B; Downes N
    Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
    Zhu X; Wang B; Zhao G; Gu J; Chen Z; Briantais P; Andres P
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcipotriol/betamethasone ointment compared to narrow-band UVB in plaque psoriasis: first clinical and ultrasonographic study.
    Polańska A; Gaura T; Bowszyc-Dmochowska M; Osmola-Mańkowska A; Olek-Hrab K; Adamski Z; Żaba R; Dańczak-Pazdrowska A
    Int J Dermatol; 2019 Jan; 58(1):108-113. PubMed ID: 30070356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.